Impact of Heart Failure and Preoperative Platelet Count on the Postoperative Short-Term Outcome in Infective Endocarditis Patients.

Junjie Wang,Suiqing Huang,Jian Hou,Kangni Feng,Huawei Wu,Quan Liu,Zhuoming Zhou,Huayang Li,Li Luo,Liqun Shang,Guangxian Chen,Zhongkai Wu

DOI: https://doi.org/10.1002/clc.24171

2024-01-01

Clinical Cardiology

Abstract:BACKGROUND:Heart failure (HF) and platelet count are often considered risk factors for mortality in patients with infective endocarditis (IE); however, their effects on various complications have not been elucidated.HYPOTHESIS:We speculated that HF and platelet count have significant impact on the short-term outcomes of IE.METHODS:This single-center retrospective study analyzed data from 320 IE patients who underwent surgery. A multivariate Cox proportional hazards model was used to identify the risk factors for adverse outcomes. The effect of the platelet count on the prognosis of patients with HF was determined by subgroup analysis and Kaplan-Meier analysis.RESULTS:The study population was divided into the HF group (n = 102) and the non-HF group (n = 218). The median age of the total population was 44.5 years (31-56 years), of which 227 (70.94%) patients were male. The incidence rates of 1-year all-cause mortality, cardiac outcomes, and composite outcomes were respectively almost sixfold, fourfold, and threefold higher in the HF group than in the non-HF group (all p < 0.001). In multivariate Cox regression analysis, HF was an independent risk factor for 1-year all-cause mortality, cardiac outcomes, cerebral outcomes, and composite outcomes. The Kaplan-Meier survival curves revealed that the patients with both HF and thrombocytopenia demonstrated the worst composite outcomes than the patients of the other groups (log-rank p < 0.001). In the HF group, the platelet count was significantly associated with mortality and composite outcomes.CONCLUSIONS:HF and preoperative platelet count are significantly associated with 1-year all-cause mortality and adverse outcomes postoperatively in IE patients. Patients with HF and thrombocytopenia have the worst short-term prognosis.